Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥11.90 - CN¥28.38
Next Earnings Date
Jun 13 2025 (Estimate)
Next Earnings Date
Jun 13 2025 (Est.)
Latest price
Market Cap | CN¥14.49B |
EV | CN¥19.05B |
Shares Outstanding | 760.10M |
Beta | 0.71 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | CN¥24.96 |
P/E 2024E | 15.80x |
P/Revenue 2024E | 0.62x |
Revenue | 17.10% |
EPS | 10.80% |
Operating Cash Flow | 23.60% |
Free Cash Flow | 26.00% |
Revenue | 8.80% |
EPS | 10.30% |
Operating Cash Flow | 2.30% |
Free Cash Flow | 6.90% |
Gross Margin 2024E | 33.74% |
Net Profit Margin 2024E | 3.77% |
ROE 2024E | 12.79% |
ROCE 2023 | 14.04% |
DPS 2024E | CN¥0.50 |
Payout Ratio 2024E | 42.37% |
Div. Yield 2024E | 2.67% |
DPS Last 3Y CAGR | 34.80% |
Price
%
1M
3M
6M
1Y
3Y
5Y
LBX Pharmacy Chain Joint Stock Company
603883
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Wang, Li
Employees
40,881
Website
www.lbxdrugs.comIPO Date
2015-04-23
Headquarters
No. 808, Qingzhuhu Road, Kaifu District, Changsha, Hunan Province, 410152, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved